PURPOSE: Klotho has been identified as a tumor suppressor in several human malignancies including hepatocellular carcinoma (HCC). However, the signaling pathways involved in the tumor suppressive role of klotho in HCC have not been reported. Here, we investigated the role of klotho in HCC cell proliferation, apoptosis, autophagy, and invasion, as well as its associated signal transduction pathways. METHODS: Restoration of klotho gene expression was established by delivering a klotho gene expression vector into the human HCC cell lines HepG2 and MHCC-97-H. Cell viability was measured using a cell counting (CCK-8) assay and apoptosis was analyzed through flow cytometry. Autophagy was measured via LC3-I and LC3-II protein expression levels and tumor cell invasion was assessed using a Matrigel invasion chamber assay. Expression and phosphorylation of several apoptosis and survival related proteins were assessed using Western blot assays. RESULTS: Exogenous klotho gene expression significantly inhibited HCC cell proliferation, induced HCC cell apoptosis, increased LC3-I and LC3-II protein expression in HCC cells, and decreased migration of HCC cells in a Matrigel invasion chamber assay. Exogenous klotho gene expression also down-regulated the phosphorylation levels of the IGF-1 receptor, and the downstream Akt, ERK, and p70S6K proteins. Both apoptosis and autophagy inhibitors decreased klotho-induced apoptosis and autophagy. CONCLUSION: Klotho is a tumor suppressor that, through the regulation of IGF-1R phosphorylation and subsequent activation of downstream Akt-p70S6K and ERK signaling, regulates HCC tumor cell proliferation, apoptosis, autophagy and invasion.
PURPOSE:Klotho has been identified as a tumor suppressor in several humanmalignancies including hepatocellular carcinoma (HCC). However, the signaling pathways involved in the tumor suppressive role of klotho in HCC have not been reported. Here, we investigated the role of klotho in HCC cell proliferation, apoptosis, autophagy, and invasion, as well as its associated signal transduction pathways. METHODS: Restoration of klotho gene expression was established by delivering a klotho gene expression vector into the human HCC cell lines HepG2 and MHCC-97-H. Cell viability was measured using a cell counting (CCK-8) assay and apoptosis was analyzed through flow cytometry. Autophagy was measured via LC3-I and LC3-II protein expression levels and tumor cell invasion was assessed using a Matrigel invasion chamber assay. Expression and phosphorylation of several apoptosis and survival related proteins were assessed using Western blot assays. RESULTS: Exogenous klotho gene expression significantly inhibited HCC cell proliferation, induced HCC cell apoptosis, increased LC3-I and LC3-II protein expression in HCC cells, and decreased migration of HCC cells in a Matrigel invasion chamber assay. Exogenous klotho gene expression also down-regulated the phosphorylation levels of the IGF-1 receptor, and the downstream Akt, ERK, and p70S6K proteins. Both apoptosis and autophagy inhibitors decreased klotho-induced apoptosis and autophagy. CONCLUSION:Klotho is a tumor suppressor that, through the regulation of IGF-1R phosphorylation and subsequent activation of downstream Akt-p70S6K and ERK signaling, regulates HCC tumor cell proliferation, apoptosis, autophagy and invasion.
Authors: Julian J Lum; Daniel E Bauer; Mei Kong; Marian H Harris; Chi Li; Tullia Lindsten; Craig B Thompson Journal: Cell Date: 2005-01-28 Impact factor: 41.582
Authors: Ci-Di Chen; Sonia Podvin; Earl Gillespie; Susan E Leeman; Carmela R Abraham Journal: Proc Natl Acad Sci U S A Date: 2007-12-03 Impact factor: 11.205
Authors: Dan E Arking; Diane M Becker; Lisa R Yanek; Daniele Fallin; Daniel P Judge; Taryn F Moy; Lewis C Becker; Harry C Dietz Journal: Am J Hum Genet Date: 2003-03-31 Impact factor: 11.025
Authors: Ci-Di Chen; Hu Li; Jennifer Liang; Kathryn Hixson; Ella Zeldich; Carmela R Abraham Journal: J Mol Neurosci Date: 2014-06-08 Impact factor: 3.444
Authors: Faith Omede; Shiqin Zhang; Cassandra Johnson; Emily Daniel; Yan Zhang; Timothy A Fields; Joseph Boulanger; Shiguang Liu; Ishfaq Ahmed; Shahid Umar; Darren Paul Wallace; Jason R Stubbs Journal: Am J Physiol Renal Physiol Date: 2019-11-04
Authors: Mingjun Shi; Brianna Flores; Nancy Gillings; Ao Bian; Han Jun Cho; Shirley Yan; Yang Liu; Beth Levine; Orson W Moe; Ming Chang Hu Journal: J Am Soc Nephrol Date: 2015-12-23 Impact factor: 10.121
Authors: Kenneth Lim; Arnoud Groen; Guerman Molostvov; Tzongshi Lu; Kathryn S Lilley; David Snead; Sean James; Ian B Wilkinson; Stephen Ting; Li-Li Hsiao; Thomas F Hiemstra; Daniel Zehnder Journal: J Clin Endocrinol Metab Date: 2015-08-17 Impact factor: 5.958